On the upside
Peregrine Pharmaceuticals (Nasdaq: PPHM) will present data from a Phase II clinical trial of its lung cancer treatment bavituximab at the 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology at the end of the week.
Chelsea Therapeutics (Nasdaq: CHTP) will present at the 14th Annual Rodman & Renshaw Global Healthcare Investment Conference on Monday, September 10.
On the downside
ARM Holdings (Nasdaq: ARMH) cited a possible slowdown in sales for lowering its hiring targets prompting a downgrade. MannKind (Nasdaq: MNKD) filed for a $500 million mixed securities shelf.
Most of the contracts covering Supervalu's (Nasdaq: SVU) unionized workers will expire this fiscal year.
In the broad market, declining issues outpaced advancers by a margin of more than 9 to 7 on both the NYSE and on Nasdaq. The Russell 2000 which tracks small cap stocks added a point to 813.